ATE377760T1 - Verfahren zum auffinden von verbindungen, die der vorsorge gegen cardiovasculäre krankheiten dienen - Google Patents

Verfahren zum auffinden von verbindungen, die der vorsorge gegen cardiovasculäre krankheiten dienen

Info

Publication number
ATE377760T1
ATE377760T1 AT02781372T AT02781372T ATE377760T1 AT E377760 T1 ATE377760 T1 AT E377760T1 AT 02781372 T AT02781372 T AT 02781372T AT 02781372 T AT02781372 T AT 02781372T AT E377760 T1 ATE377760 T1 AT E377760T1
Authority
AT
Austria
Prior art keywords
cardiovascular diseases
concentration
reducing
methods
relates
Prior art date
Application number
AT02781372T
Other languages
English (en)
Inventor
Jamila Najib
Zouher Majd
Original Assignee
Genfit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genfit filed Critical Genfit
Application granted granted Critical
Publication of ATE377760T1 publication Critical patent/ATE377760T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775—Apolipopeptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
AT02781372T 2001-09-07 2002-09-06 Verfahren zum auffinden von verbindungen, die der vorsorge gegen cardiovasculäre krankheiten dienen ATE377760T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0111598A FR2829581A1 (fr) 2001-09-07 2001-09-07 Methodes de criblage de molecules utiles pour la prevention ou le traitement du syndrome metabolique, des maladies cardiovasculaires et de l'atherosclerose

Publications (1)

Publication Number Publication Date
ATE377760T1 true ATE377760T1 (de) 2007-11-15

Family

ID=8867065

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02781372T ATE377760T1 (de) 2001-09-07 2002-09-06 Verfahren zum auffinden von verbindungen, die der vorsorge gegen cardiovasculäre krankheiten dienen

Country Status (9)

Country Link
US (1) US20040198656A1 (de)
EP (1) EP1423707B1 (de)
JP (1) JP2005502883A (de)
AT (1) ATE377760T1 (de)
CA (1) CA2459945A1 (de)
DE (1) DE60223390D1 (de)
FR (1) FR2829581A1 (de)
IL (1) IL160533A0 (de)
WO (1) WO2003023407A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006108581A2 (en) * 2005-04-15 2006-10-19 Cenix Bioscience Gmbh Human marker genes and agents for cardiovascular disorders and artherosclerosis
US7972802B2 (en) 2005-10-31 2011-07-05 University Of Washington Lipoprotein-associated markers for cardiovascular disease
JP5373322B2 (ja) * 2007-06-05 2013-12-18 株式会社バイオマーカーサイエンス 動脈硬化改善・予防効果の評価方法、物質のスクリーニング方法、並びに、マーカーとしての使用
WO2009148050A1 (ja) * 2008-06-04 2009-12-10 株式会社バイオマーカーサイエンス 動脈硬化改善・予防効果の評価方法及び評価用キット、並びに、物質のスクリーニング方法
US8241861B1 (en) 2008-07-08 2012-08-14 Insilicos, Llc Methods and compositions for diagnosis or prognosis of cardiovascular disease
MA45602A (fr) 2016-07-08 2019-05-15 Staten Biotechnology B V Anticorps anti-apoc3 et leurs méthodes d'utilisation
KR20190141659A (ko) 2017-04-21 2019-12-24 스태튼 바이오테크놀로지 비.브이. 항-apoc3 항체 및 이의 사용 방법
CN111315772A (zh) 2017-10-31 2020-06-19 斯塔顿生物技术有限公司 抗apoc3抗体及其使用方法
US10538583B2 (en) 2017-10-31 2020-01-21 Staten Biotechnology B.V. Anti-APOC3 antibodies and compositions thereof
JP7532252B2 (ja) 2018-01-10 2024-08-13 ブライトシード・インコーポレイテッド 代謝を調節するための方法
WO2021021744A1 (en) 2019-07-29 2021-02-04 Lee Chae Method for improving digestive health
EP4058007A4 (de) 2019-11-11 2024-01-03 Brightseed, Inc. Extrakt, verbrauchbares produkt und verfahren zur anreicherung von bioaktiven metaboliten in einem extrakt

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580722A (en) * 1989-07-18 1996-12-03 Oncogene Science, Inc. Methods of determining chemicals that modulate transcriptionally expression of genes associated with cardiovascular disease
EP0976824A1 (de) * 1998-07-10 2000-02-02 Amsterdam Molecular Therapeutics An der Leberregenration beteiligtes Gen und Protein
US20030032783A1 (en) * 1998-12-22 2003-02-13 Frances Yen-Potin Apolipoprotein A-IV-related protein: polypeptide, polynucleotide sequences and biallelic markers thereof
WO2000037491A2 (en) * 1998-12-22 2000-06-29 Genset Dnas encoding proteins with signal sequences
WO2001000661A2 (en) * 1999-06-25 2001-01-04 Genset Carnitine carrier related protein-1
WO2001079446A2 (en) * 2000-04-14 2001-10-25 Hyseq, Inc. Materials and methods relating to lipid metabolism

Also Published As

Publication number Publication date
CA2459945A1 (fr) 2003-03-20
FR2829581A1 (fr) 2003-03-14
EP1423707A1 (de) 2004-06-02
US20040198656A1 (en) 2004-10-07
WO2003023407A1 (fr) 2003-03-20
JP2005502883A (ja) 2005-01-27
EP1423707B1 (de) 2007-11-07
IL160533A0 (en) 2004-07-25
DE60223390D1 (de) 2007-12-20

Similar Documents

Publication Publication Date Title
ATE377760T1 (de) Verfahren zum auffinden von verbindungen, die der vorsorge gegen cardiovasculäre krankheiten dienen
NO20052928L (no) Nye kjemiske forbindelser
EE200300578A (et) Plasmi(i)n(ogeeni) eemaldamine valgulahustest
ATE456673T1 (de) Verfahren und zusammensetzungen zur messung von natriuretischen peptiden und verwendung dafür
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
DE60230029D1 (de) Immunisierungstherapie zur behandlung von atherosklerose
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
EA200501805A1 (ru) Фармацевтическая композиция, содержащая ингибитор фермента дипептидилпептидазы
ATE378404T1 (de) Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon
DE60326012D1 (de) Verfahren zur Konzentration von Proteinen
ATE381552T1 (de) Derivate von 1-piperazin- und 1- homopiperazincarboxylaten, verfahren zu deren herstellung und deren verwendung als inhibitoren des faah-enzyms
DK1427409T3 (da) Fremgangsmåde til behandling eller forhindring af vaskulær inflammation under brug af en eller flere sterolabssorptionsinhibitorer
DE602004016499D1 (de) Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung
DE602004012578D1 (de) Als inhibitoren von c-met geeignete pyrrolzusammensetzungen
DE60019321D1 (de) Verfahren zum screening von inhibitoren von asp2
EA200600459A1 (ru) Способ получения цитотоксических лимфоцитов
DE602004023824D1 (de) Verfahren zum direkten nachweis einzelner methotrexatmetabolite
NO20051169L (no) Fremgangsmate for a isolere et intestinalt kolesterolbindende protein
ATE326014T1 (de) Methode und zusammensetzungen zum vermindern des cholesterolspiegels im plasma
ATE547161T1 (de) Verfahren zur quantitativen bestimmung von poloxameren
DE60310012D1 (de) Verfahren, Assay und Kit zur Quantifizierung von HIV-Proteasehemmer
DE50207801D1 (de) Verfahren zum Nachweis prokaryontischer DNA
DE50212790D1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
BR0312282A (pt) Processo para o enriquecimento e detecção de proteìnas de priÈnios patologicamente modificadas (prpsc)
DE60321355D1 (de) Verfahren zur reproduzierung von pleuromutilinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties